Recruiting studies: Premature Atherosclerosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-
Phase 2 · 1 location(s) · National Institute of Arthritis and Musculoskeletal and Skin · NCT05440422 PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis
Phase 3 · 23 location(s) · Duke University · NCT07232069 Pakistan Study of Premature Coronary Atherosclerosis in Young Adults
Phase N/A · 1 location(s) · Tabba Heart Institute · NCT05156736

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.